U.S. and China likely to extend trade truce to delay sky-high tariffs

The United States and China are commencing their third round of trade talks, aiming to extend a truce and de-escalate tariffs, with the U.S. having recently softened its stance, including allowing Nvidia AI chip sales. China enters negotiations with increased leverage, bolstered by 5.3% H1 2025 economic growth and its dominance in rare earth processing, having previously used export restrictions as a bargaining chip. While the U.S. seeks commitments on fentanyl and a reduced trade deficit, China's support for Russia remains a significant point of contention, even as the U.S. finalizes other trade deals globally.

Analysis

The United States and China are entering a third round of trade negotiations with a demonstrably altered dynamic. While the immediate goal is to extend a trade truce that lowered U.S. tariffs on Chinese goods to 30% and Chinese tariffs on U.S. products to 10%, China is negotiating from a position of increased strength. This leverage is underpinned by better-than-expected economic performance, with 5.3% GDP growth in the first half of 2025, and its strategic dominance in the rare earths sector, where it controls over 90% of global processing. China effectively weaponized this position by imposing export restrictions in April, which prompted a softening U.S. stance and subsequent loosening of those same restrictions in June. A key U.S. concession has been the reversal of a ban on Nvidia's H20 AI chip sales to China, a move that signals a willingness to negotiate on sensitive technology exports. Despite official U.S. commentary describing the talks as "constructive," significant friction points remain, most notably China's support for Russia's war in Ukraine and U.S. demands for action on fentanyl. In return for potential tariff concessions, China is seeking "more certainty" regarding the easing of semiconductor restrictions, indicating this is a primary objective.

Key Decisions for Investors

• The U.S. reversal on the Nvidia H20 AI chip ban is a significant positive catalyst for semiconductor firms with high exposure to the Chinese market; investors should monitor the talks for further easing of tech export controls.
• China's use of its dominance in rare earth processing as a negotiating tool highlights a critical supply chain vulnerability for the U.S. defense, technology, and healthcare sectors, warranting a portfolio risk review for companies dependent on these materials.
• Despite a constructive tone on trade, key geopolitical tensions, particularly China's support for Russia, represent a significant source of headline risk that could derail progress and reintroduce market volatility.
• While a potential extension of the trade truce could provide near-term relief, investors should watch whether a final agreement provides the 'certainty' on U.S. restrictions that Beijing is seeking, as this would be a major indicator of a more stable, long-term trade relationship.